Screener
Keros Therapeutics KROS Q1 2026 earnings
Reported May 14, 2026 · Before market open
Revenue$367.0KMiss by $1.6M
EPS-$1.21Miss by $0.19
Revenue estimate$1.9M
EPS estimate-$1.02
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$14.8M
EPS estimate-$0.96
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Keros Therapeutics report Q1 2026 earnings?
- Keros Therapeutics (KROS) reported Q1 2026 earnings on May 14, 2026 before market open.
- What were Keros Therapeutics's Q1 2026 revenue and EPS?
- Keros Therapeutics reported revenue of $367.0K and eps of $-1.21 for Q1 2026.
- Did Keros Therapeutics beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $1.9M by $1.6M. EPS missed the consensus estimate of $-1.02 by $0.19.
- How did Keros Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 99.8% from $211.2M a year earlier.
- Where can I find Keros Therapeutics's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001664710-26-000029) and the 10-Q periodic report (0001664710-26-000030) directly on SEC EDGAR. The filing index links above go to sec.gov.
